| 臺大學術典藏 |
2020-05-04T08:02:23Z |
Job Dispatching and Scheduling for Heterogeneous Clusters-A Case Study on the Billing Subsystem of CHT Telecommunication
|
Lin, T.-C.;Lin, C.-C.;Chang, T.-W.;Liu, P.;Wu, J.-J.;Shih, C.-C.;Huang, C.-W.; Lin, T.-C.; Lin, C.-C.; Chang, T.-W.; Liu, P.; Wu, J.-J.; Shih, C.-C.; Huang, C.-W.; PANGFENG LIU |
| 臺大學術典藏 |
2020-05-04T08:02:19Z |
Communication Scheduling Optimization for Distributed Deep Learning Systems
|
PANGFENG LIU; Wu, J.-J.; Tsai, C.-Y.;Lin, C.-C.;Liu, P.;Wu, J.-J.; Tsai, C.-Y.; Lin, C.-C.; Liu, P. |
| 臺大學術典藏 |
2020-05-04T07:56:29Z |
Decapitation via digital epidemics: A bio-inspired transmissive attack
|
Chen, P.-Y.; Lin, C.-C.; Cheng, S.-M.; Hsiao, H.-C.; Huang, C.-Y.; HSU-CHUN HSIAO |
| 臺大學術典藏 |
2020-05-04T07:56:28Z |
Traffic-aware patching for cyber security in mobile IoT
|
Cheng, S.-M.; Chen, P.-Y.; Lin, C.-C.; Hsiao, H.-C.; HSU-CHUN HSIAO |
| 臺大學術典藏 |
2020-04-28T07:25:40Z |
A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer
|
Lin C.-C.;Chih-Hung Hsu;Chen J.;Tsai T.-C.;Cheng A.-L.;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Chen J.; Tsai T.-C.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2020-04-28T07:25:38Z |
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
|
Chih-Hung Hsu;Cheng A.-L.;Hsu C.;Yang C.-H.;Lu Y.-S.;Lin C.-C.;Bu C.-F.;Yeh K.-H.; CHIH-HUNG HSU; Cheng A.-L.; Hsu C.; Yang C.-H.; Lu Y.-S.; Lin C.-C.; Bu C.-F.; Yeh K.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:34Z |
Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: A two-case study
|
Lin C.-C.;Chih-Hung Hsu;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Pu Y.-S. |
| 臺大學術典藏 |
2020-04-28T07:25:34Z |
Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity
|
Lin C.-C.;Chih-Hung Hsu;Huang C.-Y.;Cheng A.-L.;Chen J.;Vogelzang N.J.;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S. |
| 臺大學術典藏 |
2020-04-28T07:25:32Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Pu Y.-S.;Cheng A.-L.;Huang K.-H.;Tsai Y.-C.;Huang C.-Y.;CHIH-HUNG HSU;Lin C.-C.; Lin C.-C.; CHIH-HUNG HSU; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2020-04-28T07:25:31Z |
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
|
CHIH-HUNG HSU;Cheng A.-L.;Hsu W.-L.;Tsai Y.-C.;Hsu C.;Yang C.-H.;Yeh K.-H.;Lin C.-C.; Lin C.-C.; Yeh K.-H.; Yang C.-H.; Hsu C.; Tsai Y.-C.; Hsu W.-L.; Cheng A.-L.; CHIH-HUNG HSU |
